P04.4 Newborn affected by maternal use of drugs of addiction

Name of the Condition

• Newborn affected by maternal use of drugs of addiction
• ICD Code: P04.4

Summary

This condition describes health effects in a newborn resulting from maternal use of drugs of addiction during pregnancy or breastfeeding. The newborn may exhibit signs or symptoms due to exposure to these substances, which can impact neonatal adaptation and health.

Causes

Maternal use of drugs of addiction, such as opioids, stimulants, or other illicit substances, can cross the placenta and affect the fetus. Postnatally, substances in breast milk may also cause adverse effects in the newborn. The specific drugs and their timing of exposure influence the newborn's condition.

Risk Factors

• Maternal use of drugs of addiction during pregnancy
• Lack of prenatal screening for substance use
• Breastfeeding while using harmful substances
• Prolonged or high-dose exposure to these agents
• Maternal health conditions related to substance use

Symptoms

Symptoms vary based on the substance and timing of exposure. Common signs include respiratory distress, poor feeding, lethargy, jitteriness, or withdrawal symptoms. Some newborns may exhibit growth restriction, neurodevelopmental issues, or congenital anomalies.

Diagnosis

Diagnosis involves a thorough maternal history review, including substance use details, newborn clinical assessment, and laboratory tests if needed. Documentation of maternal drug use is critical for correlation with neonatal findings.

Treatment Options

Treatment focuses on managing symptoms, such as respiratory support, feeding assistance, or medication for withdrawal. Neonatal care may include monitoring for complications and providing supportive care tailored to the newborn's needs.

Prognosis and Follow-Up

Prognosis depends on the substance, duration of exposure, and newborn's response. Follow-up may involve developmental assessments, monitoring for long-term effects, and coordination with pediatric specialists. Early intervention can improve outcomes.

Complications

Complications may include respiratory failure, seizures, growth restriction, or neurodevelopmental delays. Severe cases can lead to hospitalization or long-term health issues requiring ongoing care.

Lifestyle & Prevention

Prevention involves maternal education on the risks of substance use during pregnancy, access to addiction treatment, and prenatal screening. Avoiding drug use and seeking support can reduce exposure risks.

When to Seek Professional Help

Seek medical attention if the newborn shows signs of distress, poor feeding, or withdrawal symptoms. Maternal substance use should be disclosed to healthcare providers for appropriate neonatal care.

Tips for Medical Coders

Document maternal drug use details, including timing and type of substance, to support coding accuracy. Ensure correlation between maternal history and neonatal findings. Code P04.4 is specific to drugs of addiction; avoid using for other maternal medications or substances.